Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: A retrospective case-control study with cost analysis

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 8, 2002, Pages 1529-1538

  Gournay, J ^a,d   Tchuenbou, J ^a   Richou, C ^a   Masliah, C ^a   Lerat, F ^a   Dupas, B ^a   Martin, T ^b   Nouel, J F ^b   Schnee M ^c   Montigny, P ^c   D'Alincourt, A ^a   Hamy, A ^a   Paineau, J ^a   Le Neel J C ^a   Le Borgne, J ^a   Galmiche, J P ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Centre Hospitalier de Saint Nazaire   (France)

^c La Roche sur Yon Hospital   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ALCOHOL METABOLISM; ARTICLE; CALCULATION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; FRANCE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SKIN ABSORPTION; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; INTRALESIONAL DRUG ADMINISTRATION; LENGTH OF STAY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COMPARATIVE STUDY; COST-BENEFIT ANALYSIS; ETHANOL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEALTH CARE COSTS; HEPATECTOMY; HUMAN; INJECTIONS, INTRALESIONAL; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0036668711     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01307.x     Document Type: Article

References (34)

1. Rising incidence of hepatocellular carcinoma in the United States
2. Screening for hepatocellular carcinoma
3. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
4. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis
5. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
6. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection
7. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
8. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective
9. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis
10. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
11. Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients
12. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
13. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series
14. Resection of malignant primary liver tumors
15. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan
16. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study
17. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma
18. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
19. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: Analysis of 71 patients
20. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: Helical CT patterns
21. Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy
22. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma
23. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection
24. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection
25. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy
26. Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection
27. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates
28. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma - A study based on 420 patients
29. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection
30. Essaimage tumoraux sur le trajet de ponctions écho-guidées de carcinomes hépatocellulaires. Etude de 150 malades
31. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma
32. Résection des carcinomes hépatocellulaires. Analyse des facteurs pronostiques d'une série multicentrique de 153 malades
33. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients
34. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients